The Biotech Race to Make Aging Treatable

By The Numbers

$44 billion - projected global longevity biotech market size by 2030 (Grand View Research)
$3+ billion - raised by Altos Labs at its 2022 launch, backed by Jeff Bezos (Bloomberg)
700+ - longevity-focused companies now operating globally, up from under 100 a decade ago (Longevity.Technology)
10-14% - average lifespan extension recorded in mice treated with mTOR inhibitors across multiple trials (NIA Interventions Testing Program)

For most of human history, aging was just the tax you paid for being alive. Nobody questioned it. Then a handful of scientists started asking a different question: what if it was a disease? That question - once considered fringe - has now attracted billions of dollars, the smartest money in the world, and a growing pipeline of drugs in actual clinical trials.

Jeff Bezos backed Altos Labs with a reported $3 billion at its 2022 launch. Alphabet created an entire subsidiary, Calico Labs, and committed $1.5 billion to studying the fundamental biology of lifespan. These are not curiosity investments - when people with their track record write billion-dollar checks into a sector, that tells you something real about where the technology is headed.

We broke down the key names - public plays, indirect exposure, and what to watch over the next 12 months. Full story is on the site.

Read the full story →

You are receiving this e-mail at {{$sys_email.email_address}}, as part of your subscription to Smart Investing Daily. No longer interested? Unsubscribe.

Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before our subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after on-line publication prior to following an initial recommendation.

Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: First Light Financial, 14 West Mt Vernon Place, Baltimore, MD 21201. Smart Investing Daily is a First Light Financial, LLC publication. To contact us call 866-616-2166 or visit us online.

Website | Privacy Policy | Terms & Conditions

Big Key Marketing, 14 West Mt Vernon Place · Maryland · Baltimore · 21201 · United States

No longer want to receive these emails. Unsubscribe

Famous Jewelry Collections

Friday, June 12, 2026

The Biotech Race to Make Aging Treatable

The Biotech Race to Make Aging Treatable

No comments:

Post a Comment